PAVmed Recruits Sodexo Executive for its Board of Directors

PAVmed Inc., a differentiated, multi-product, commercial-stage medical technology company, has appointed U.K.-based global industry executive Debbie White to its Board of Directors. White will serve on the company’s Audit and Compensation Committees.
 
“I am delighted to welcome Debbie White to PAVmed’s Board of Directors,” said Lishan Aklog M.D., PAVmed’s chairman and CEO. “Debbie has broad business leadership experience, including as a chief executive, financial executive, public company director and strategic consultant, in multiple sectors in Europe and the United States, including the healthcare services, molecular genetics and biopharmaceutical industries. She will provide valuable guidance on strategy, operations, finance and international commercialization as PAVmed transitions to a growth-stage commercial company.”
 
White currently serves on the board of directors of Howden Joinery Group PLC, a U.K.-headquartered multinational building trade supplier with 10,000 employees and more than $2 billion in revenue and as a trustee of Wellbeing of Women, a U.K. charity that invests in medical research and development of specialist clinicians in women’s health. White recently served as a strategic consultant to Oxford Nanopore Technologies Ltd., a U.K. biotechnology company that develops and commercializes DNA/RNA sequencing technologies, and its emerging Oxford Nanopore Diagnostics business unit.
 
Early in the COVID-19 pandemic, White worked with the U.K. government to help establish COVID-19 testing facilities across the nation.
 
White previously served as group CEO of Interserve Group, a U.K.-headquartered multinational group of support services and construction companies with 75,000 employees and more than $4 billion in revenue, during a challenging period which required her to implement complex strategic financing and operational programs prior to its restructuring and sale to its creditors.
 
Prior to Interserve, White spent 13 years in senior executive roles at Sodexo SA, a Paris-headquartered multinational diversified services company with 440,000 employees and over $20 billion in revenue, including as CEO of Sodexo U.K. and Ireland, chief financial officer of Sodexo North America, an $8 billion subsidiary, and finally as executive board member and global CEO of Healthcare and Government, two global businesses with a combined 100,000 employees and over $7 billion in revenue. While at Sodexo, she served on its global body that promoted the development of women across the company and was inducted into the industry’s Women 1st Top 100 Club, which highlights the female role models and leaders who have achieved success at the highest levels.
 
Prior to Sodexo, White served for three years as a director at PWC Consulting, advising a range of industries, including pharmaceuticals, on integration, financial performance improvement and post-merger integration, and for 13 years in various financial and strategic roles at AstraZeneca, a U.K.-headquartered multinational pharmaceutical and biotechnology company. She began her career as a senior tax advisor at Arthur Andersen & Co.

White received her master’s degree in Economics from Cambridge University, Cambridge U.K.

“I am very excited to join this rapidly-growing innovative company with groundbreaking medical technologies, which have the potential to greatly improve patient care and save lives across the world,” said White. “I look forward to working with Dr. Aklog, the rest of PAVmed’s strong management team and my respected board colleagues to hone and execute the company’s long-term growth strategy.”